GATA1-deficient human pluripotent stem cells generate neutrophils with improved antifungal immunity that is mediated by the integrin CD18
PLOS Pathogens · 2025
DOI: 10.1371/journal.ppat.1012654 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Andrew S Wagner und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Immunology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of…. Hauptthemen laut MEDLINE: Neutrophils, Aspergillus fumigatus, GATA1 Transcription Factor, CD18 Antigens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Neutrophils are critical for host defense against fungi. However, the short life span and lack of genetic tractability of primary human neutrophils has limited in vitro analysis of neutrophil-fungal interactions. Human induced pluripotent stem cell (iPSC)-derived neutrophils (iNeutrophils) provide a genetically tractable system to study host defense responses of human neutrophils. Here, we show that deletion of the transcription factor GATA1 from human iPSCs results in iNeutrophils with improved antifungal activity against Aspergillus fumigatus . GATA1-knockout (KO) iNeutrophils have increased maturation, antifungal pattern recognition receptor expression and have improved neutrophil effector functions compared to wild-type iNeutrophils. iNeutrophils also show a shift in their metabolism following stimulation with fungal β-glucan to the pentose phosphate pathway (PPP), similar to primary human neutrophils. Furthermore, we show that deletion of the integrin CD18 attenuates the ability of GATA1-KO iNeutrophils to kill A. fumigatus but is not necessary for the metabolic shift . Collectively, these findings support iNeutrophils as a robust system to study human neutrophil antifungal immunity and has identified specific roles for CD18 in the defense response .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology and Immunology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.
- Department of Pediatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, United States of America.
- Morgridge Institute for Research, Madison, Wisconsin, United States of America.
- Department of Plant Pathology, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
ORCID-Profile: Anna Huttenlocher
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- NHLBI NIH HHS
- NIBIB NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Wagner, A. S., Smith, F. M., Bennin, D. A., Votava, J. A., Datta, R., Giese, M. A., Zhao, W., Skala, M. C., Fan, J., Keller, N. P., & Huttenlocher, A. (2025). GATA1-deficient human pluripotent stem cells generate neutrophils with improved antifungal immunity that is mediated by the integrin CD18. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012654
Vancouver
Wagner AS, Smith FM, Bennin DA, Votava JA, Datta R, Giese MA, et al. GATA1-deficient human pluripotent stem cells generate neutrophils with improved antifungal immunity that is mediated by the integrin CD18. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1012654
BibTeX
@article{Wagner2025,
author = {Wagner, Andrew S and Smith, Frances M and Bennin, David A and Votava, James A and Datta, Rupsa and Giese, Morgan A and Zhao, Wenxuan and Skala, Melissa C and Fan, Jing and Keller, Nancy P and Huttenlocher, Anna},
title = {GATA1-deficient human pluripotent stem cells generate neutrophils with improved antifungal immunity that is mediated by the integrin CD18},
journal = {PLOS Pathogens},
year = {2025},
doi = {10.1371/journal.ppat.1012654}
}
EUVIMED